HOME >> MEDICINE >> NEWS
Routine overnight EEG monitoring not warranted in autistic children

DENVER, CO -- Though controversial, children with autistic syndrome may be subjected unnecessarily to overnight EEG testing for the identification of Landau-Kleffner syndrome (LKS), the deterioration of language ability associated with clinical or electrical seizure activity. According to research presented at the annual meeting of the American Academy of Neurology, this type of monitoring is unwarranted except in highly selected cases.

We found the incidence of the diagnostic criteria for LKS to be miniscule in overnight studies of 334 patients studied with the indication of autism spectrum disorder, says study author Phillip Pearl, MD, of Childrens National Medical Center in Washington, DC.

This suggests to us that this kind of testing may not the most effective way to diagnose LKS among children with autism.

Of 894 Childrens National Medical Center patients monitored over 3.5 years, 334 (37%) were identified as having autism spectrum disorder and studied to rule out LKS. Of these, 83 (25%) had abnormal EEGs, with 63 (19%) exhibiting epileptiform activity. The overnight EEG studies identified epileptiform activity during sleep in 56 of the 63 patients; none of these tracings revealed electrographic status epilepticus during slow-wave sleep, regarded as a diagnostic criterion for LKS.

Overnight EEG monitoring in autistic children is challenging on multiple accounts, and oftentimes requires sedation for the child to undergo the hook-up procedure. These studies are unwarranted as a routine investigation for children with autism, says Pearl. Landau-Kleffner syndrome, or acquired epileptiform aphasia, represents a disorder that can be distinguished from autism on several accounts, according to Pearl. While the children may not have clinical seizures at all, there are clinical clues that allow a neurologist to suspect this syndrome. We recommend overnight EEG monitoring in selected patients with autistic syndrome, s
'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
16-Apr-2002


Page: 1 2

Related medicine news :

1. Routine dental panoramic X-rays not necessary, study shows
2. Routine HIV screening should be expanded, study finds
3. Routine use of nose-to-stomach tube slows recovery from abdominal surgery
4. Study Of Women And Hearing Reveals Need For Routine Hearing Tests
5. Routine Use Of Coronary Stents Found To Yield Better Outcomes, Be More Cost-Effective
6. Routine Dental X-ray May Be A Valuable Tool In Stroke Prevention
7. Study compares overnight dialysis to treatment in centers
8. Dual testing better for monitoring new cases of HIV
9. Panel offers recommendations for monitoring adverse events from dietary supplements
10. Data announced at ISHLT: Molecular testing proves effective in monitoring heart transplant rejection
11. Continuous insulin monitoring does not raise hospital costs

Post Your Comments:
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted an ... details the development of RT001, a form of topical botulinum ... trials. For those afraid of needles, the idea of a ... if the drug ultimately gets FDA approval it will be ... , “As the article notes, the size of the ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 The winter ... mold growth and expansion. When mold grows, it can be ... be sure to avoid the consequences of mold growth with ... Long Island, is offering tips on the best ways to ... wet season, which makes perfect conditions for mold to thrive. ...
(Date:2/27/2015)... Vancouver, BC (PRWEB) February 27, 2015 ... exciting overnight deals for couples who wanted to spend ... with the opportunity to get a jump on Valentine’s ... meal and stay in one of their luxurious rooms. ... on February 13, inviting guests for a mouthwatering 3 ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being ... Gold Plus hospital. In order to receive the award, ... to all Get With The Guidelines - Stroke Quality ... and achieved 75-percent or higher compliance with six of ... These are reporting initiatives to measure quality of care. ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2
(Date:2/27/2015)... Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the fourth quarter and full ... was a transformative year for PTC. We are now ... developing RNA-targeted therapies in the rare disease space," stated ... Inc. "We are proud to bring the first treatment ...
(Date:2/27/2015)... 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... it acquired Bionik Laboratories, Inc., a Toronto ... to qualified accredited investors of units consisting of its ... approximately $6.2 million. Shares of the Company,s common stock ... under the symbol "DWTPD" until FINRA,s approval of the ...
(Date:2/26/2015)... -- RnRMarketResearch.com adds Corneal Ulcers - ... its store. This report p provides an overview ... The report "Corneal Ulcers - Pipeline Review, H2 2014" provides ... Ulcers. Corneal Ulcers are primarily result of the ... & fungal infections. The symptoms of the corneal ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
Cached News: